Table of Content - Pigmentation Disorders Treatment Market

Global pigmentation disorders treatment market is estimated to be valued at USD 7.33 Bn in 2024 and is expected to exhibit a CAGR of 9.2% during the forecast period (2024-2031). Pigmentation disorders refer to conditions characterized by changes in skin color that are usually caused due to excess or uneven distribution of melanin. The global pigmentation disorders treatment market has been growing significantly over the recent past owing to the rising prevalence of conditions like melasma, vitiligo, and post-inflammatory hyperpigmentation. Various factors such as increasing awareness regarding pigmentation treatment options, growing aging population vulnerable to such disorders, and continual launch of advanced therapeutics are fueling the market expansion. However, high cost of sophisticated treatments, risks and side effects associated with certain medications remain major challenges for the market.

Market Dynamics:

The global pigmentation disorders treatment market is primarily driven by the increasing prevalence of pigmentation disorders worldwide due to genetic predisposition as well as changes in lifestyle habits. According to recent estimates, nearly 1-2% of global population suffers from vitiligo while prevalence of melasma ranges between 4-10%. Growing geriatric population also prone to such skin conditions acts as a high-impact driver. Moreover, continual development of newer topical and oral medications with fewer side effects along with entry of biosimilars is creating ample opportunities in this space. However, the market growth can be hampered by certain factors including stringent regulations for approval of melanogenesis inhibitors, reluctance towards cosmetic procedures due to social taboo, and high costs involved particularly in emerging nations.

Key Features of the Study:

This report provides in-depth analysis of the global pigmentation disorders treatment market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global pigmentation disorders treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Abbvie Inc., Edesa Biotech, Inc., Amgen, Inc., Pfizer Inc., CLINUVEL PHARMACEUTICALS LTD, Uniza Group, Dr. Reddy’s Laboratories Ltd., Roivant Sciences Ltd., Incyte, Aclaris Therapeutics, Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Viatris Inc., GSK plc., Vyne Therapeutics Inc., Temprian Therapeutics Inc., Arrien Pharmaceuticals, LLC.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global pigmentation disorders treatment market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pigmentation disorders treatment market.

Detailed Segmentation-

By Disorder Type:
- Melasma
- Vitiligo
- Albinism
- Post-Inflammatory Hyperpigmentation (PIH)
- Others
By Drug Type:
- Corticosteroids
- Calcineurin Inhibitors
- Janus kinase (JAK) inhibitor
- Melanin Synthesis Inhibitor
- Others
By Route of Administration:
- Oral
- Topical
- Other
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa

Company Profiles:

Abbvie Inc.
Edesa Biotech, Inc.
Amgen, Inc.
Pfizer Inc.
CLINUVEL PHARMACEUTICALS LTD
Uniza Group
Reddy’s Laboratories Ltd.
Roivant Sciences Ltd.
Incyte
Aclaris Therapeutics, Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Viatris Inc.
GSK plc.
Vyne Therapeutics Inc.
Temprian Therapeutics Inc.
Arrien Pharmaceuticals, LLC

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Disorder Type
  - Market Snapshot, By Drug Type
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Pipeline Analysis
- Epidemiology
- Pricing and Brand Analysis
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter’s Analysis
Global Pigmentation Disorders Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
Global Pigmentation Disorders Treatment Market, By Disorder Type, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Melasma
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Vitiligo
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Albinism
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Post-Inflammatory Hyperpigmentation (PIH)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Pigmentation Disorders Treatment Market, By Drug Type, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Corticosteroids
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Calcineurin Inhibitors
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Janus kinase (JAK) inhibitor
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Melanin Synthesis Inhibitor
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Pigmentation Disorders Treatment Market, By Route of Administration, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Oral
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Topical
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Pigmentation Disorders Treatment Market, By Distribution Channel, 2019 – 2031, (USD Bn)
- Overview
  - Market Share Analysis, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, 2019 – 2031
  - Segment Trends
- Hospital Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Retail Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Online Pharmacies
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Global Pigmentation Disorders Treatment Market, By Region, 2019 – 2031, (USD Bn)
- Introduction
  - Market Share Analysis, By Region, 2024 and 2031 (%)
  - Y-o-Y Growth Analysis, For Regions, 2019–2031
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Disorder Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Abbvie Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Edesa Biotech, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Amgen, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Pfizer Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - CLINUVEL PHARMACEUTICALS LTD
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Uniza Group
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Dr. Reddy’s Laboratories Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Roivant Sciences Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Incyte
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Aclaris Therapeutics, Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Glenmark Pharmaceuticals Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Sun Pharmaceutical Industries Ltd.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Viatris Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - GSK plc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Vyne Therapeutics Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Temprian Therapeutics Inc.
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
  - Arrien Pharmaceuticals, LLC
    - Company Highlights
    - Product Portfolio
    - Key Highlights
    - Financial Performance
    - Market Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

*Browse 32 market data tables and 30 figures on "Pigmentation Disorders Treatment Market” -Global forecast to 2031

View Our Licence Options

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount